Trikafta
List of products in the National Drug Code with proprietary name trikafta. This product has 2 different tablets. One tablet contains 3 medications (it is a "multi-drug"): elexacaftor, tezacaftor, and ivacaftor. The other tablet contains only ivacaftor. This product is used to treat cystic fibrosis in certain people (those with an abnormal "CFTR" gene). It may help to improve breathing, reduce the risk of lung infections, and improve weight gain.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 51167-106 | Trikafta | Elexacaftor, Tezacaftor, And Ivacaftor | Kit | Vertex Pharmaceuticals Incorporated | Human Prescription Drug | |
| 51167-331 | Trikafta | Elexacaftor, Tezacaftor, And Ivacaftor | Kit | Vertex Pharmaceuticals Incorporated | Human Prescription Drug | |
| 51167-445 | Trikafta | Elexacaftor, Tezacaftor, And Ivacaftor | Kit | Vertex Pharmaceuticals Incorporated | Human Prescription Drug | |
| 51167-446 | Trikafta | Elexacaftor, Tezacaftor, And Ivacaftor | Kit | Vertex Pharmaceuticals Incorporated | Human Prescription Drug |